Suppr超能文献

蛋白酶抑制剂亮抑蛋白酶肽会干扰海马切片中长时程增强效应的形成。

The protease inhibitor leupeptin interferes with the development of LTP in hippocampal slices.

作者信息

Oliver M W, Baudry M, Lynch G

机构信息

Center for the Neurobiology of Learning and Memory, University of California, Irvine 92717.

出版信息

Brain Res. 1989 Dec 29;505(2):233-8. doi: 10.1016/0006-8993(89)91448-0.

Abstract

The effect of leupeptin, an inhibitor of thiol-proteases, was tested on the induction of long-term potentiation (LTP) in field CA1 of hippocampal slices. Two h of drug application did not produce substantial changes while a greater than 3-h application caused a sizeable reduction in the degree of LTP induced. Leupeptin had no obvious effects on the facilitation of postsynaptic responses occurring within or between the short high frequency bursts used to induce LTP, suggesting that the drug acted on cellular chemistries occurring after the initial physiological events that normally trigger LTP. These results are consistent with the hypothesis that a calcium-activated thiol protease (calpain) is involved in the induction of LTP.

摘要

巯基蛋白酶抑制剂亮肽素对海马切片CA1区长期增强(LTP)诱导作用的影响进行了测试。给药两小时未产生显著变化,而给药超过三小时会导致诱导的LTP程度大幅降低。亮肽素对用于诱导LTP的短高频爆发期间或之间发生的突触后反应的促进作用没有明显影响,这表明该药物作用于通常触发LTP的初始生理事件之后发生的细胞化学过程。这些结果与钙激活巯基蛋白酶(钙蛋白酶)参与LTP诱导的假说一致。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验